RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area
Labouèbe, Gwenaël, Lomazzi, Marta, Cruz, Hans G, Creton, Cyril, Luján, Rafael, Li, Meng, Yanagawa, Yuchio, Obata, Kunihiko, Watanabe, Masahiko, Wickman, Kevin, Boyer, Stephanie B, Slesinger, Paul A, Lüscher, Christian
Published in Nature neuroscience (01.12.2007)
Published in Nature neuroscience (01.12.2007)
Get full text
Journal Article
Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system
Cruz, Hans G, Ivanova, Tatiana, Lunn, Marie-Louise, Stoffel, Markus, Slesinger, Paul A, Luscher, Christian
Published in Nature neuroscience (01.02.2004)
Published in Nature neuroscience (01.02.2004)
Get full text
Journal Article
Absence and Rescue of Morphine Withdrawal in GIRK/Kir3 Knock-out Mice
Cruz, Hans G, Berton, Frederique, Sollini, Monica, Blanchet, Christophe, Pravetoni, Marco, Wickman, Kevin, Luscher, Christian
Published in The Journal of neuroscience (09.04.2008)
Published in The Journal of neuroscience (09.04.2008)
Get full text
Journal Article
Exposure–response analysis of Camidanlumab tesirine in patients with relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma
Toukam, Marie, Boni, Joseph P., Hamadani, Mehdi, Caimi, Paolo F., Cruz, Hans G., Wuerthner, Jens
Published in Cancer chemotherapy and pharmacology (2023)
Published in Cancer chemotherapy and pharmacology (2023)
Get full text
Journal Article
Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma
Toukam, Marie, Wuerthner, Jens, Havenith, Karin, Hamadani, Mehdi, Caimi, Paolo F., Kopotsha, Tim, Cruz, Hans G., Boni, Joseph P.
Published in Cancer chemotherapy and pharmacology (2023)
Published in Cancer chemotherapy and pharmacology (2023)
Get full text
Journal Article
Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment
Kaufmann, Priska, Cruz, Hans G., Krause, Andreas, Ulč, Ivan, Halabi, Atef, Dingemanse, Jasper
Published in British journal of clinical pharmacology (01.08.2016)
Published in British journal of clinical pharmacology (01.08.2016)
Get full text
Journal Article
Biomarker‐guided clinical development of the first‐in‐class anti‐inflammatory FPR2/ALX agonist ACT‐389949
Stalder, Anna K., Lott, Dominik, Strasser, Daniel S., Cruz, Hans G., Krause, Andreas, Groenen, Peter M.A., Dingemanse, Jasper
Published in British journal of clinical pharmacology (01.03.2017)
Published in British journal of clinical pharmacology (01.03.2017)
Get full text
Journal Article
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Goldberg, Aaron D., Atallah, Ehab, Rizzieri, David, Walter, Roland B., Chung, Ki-Young, Spira, Alexander, Stock, Wendy, Tallman, Martin S., Cruz, Hans G., Boni, Joseph, Havenith, Karin E.G., Chao, Grace, Feingold, Jay M., Wuerthner, Jens, Solh, Melhem
Published in Leukemia research (01.08.2020)
Published in Leukemia research (01.08.2020)
Get full text
Journal Article
Assessment of the Abuse Liability of a Dual Orexin Receptor Antagonist: A Crossover Study of Almorexant and Zolpidem in Recreational Drug Users
Cruz, Hans G., Hoever, Petra, Chakraborty, Bijan, Schoedel, Kerri, Sellers, Edward M., Dingemanse, Jasper
Published in CNS drugs (01.04.2014)
Published in CNS drugs (01.04.2014)
Get full text
Journal Article
Pharmacokinetic and pharmacodynamic interactions between almorexant, a dual orexin receptor antagonist, and desipramine
Cruz, Hans G, Hay, Justin L, Hoever, Petra, Alessi, Federica, te Beek, Erik T, van Gerven, Joop M.A, Dingemanse, Jasper
Published in European neuropsychopharmacology (01.08.2014)
Published in European neuropsychopharmacology (01.08.2014)
Get full text
Journal Article
CD25, Soluble CD25, and CCL17 As Potential Predictors of Clinical Response to Camidanlumab Tesirine in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
Dyczkowski, Jerzy, Herrera, Alex F., Carlo-Stella, Carmelo, Zinzani, Pier Luigi, Toukam, Marie, Cruz, Hans G., Havenith, Karin, Boni, Joseph, Wuerthner, Jens, Pantano, Serafino
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Pharmacokinetic and Pharmacodynamic Correlates from the Phase 1 Study of Camidanlumab Tesirine (Cami) in Patients with Relapsed or Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Boni, Joseph, Havenith, Karin, Hamadani, Mehdi, Caimi, Paolo F, Anderson, Katie, Kopotsha, Tim, Cruz, Hans G, Wuerthner, Jens
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Preliminary Results of a Phase 2 Study of Camidanlumab Tesirine (Cami), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Hodgkin Lymphoma
Herrera, Alex F., Carlo-Stella, Carmelo, Collins, Graham P., Maddocks, Kami J., Bartlett, Nancy L., Savage, Kerry J., Caimi, Paolo F, Hess, Brian T., Zinzani, Pier Luigi, Cruz, Hans G, Wang, Luqiang, Feingold, Jay, Wuerthner, Jens, Ansell, Stephen M.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Exploratory Analysis of Factors Influencing Efficacy and Safety of Camidanlumab Tesirine: Data from the Open-Label, Multicenter, Phase 2 Study of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
Herrera, Alex F., Ansell, Stephen M., Zinzani, Pier Luigi, Radford, John, Maddocks, Kami J., Pinto, Antonio, Collins, Graham P., Bachanova, Veronika, Bartlett, Nancy L., Bence-Bruckler, Isabelle, Hamadani, Mehdi, Kline, Justin, Mayer, Jiri, Savage, Kerry J., Advani, Ranjana H., Caimi, Paolo F., Casasnovas, René-Olivier, Feldman, Tatyana A., Hess, Brian T., Bastos-Oreiro, Mariana, Iyengar, Sunil, Szomor, Árpád, Townsend, William, Andre, Marc, Dyczkowski, Jerzy, Eisen, Sandy, Urban, Andrzej, Pantano, Serafino, Cruz, Hans G., Wang, Luqiang, Negievich, Yanina, Wuerthner, Jens, Carlo-Stella, Carmelo
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system
Cruz, Hans G, Ivanova, Tatiana, Lunn, Marie-Louise, Stoffel, Markus, Slesinger, Paul A, Lüscher, Christian
Published in Nature neuroscience (01.02.2004)
Published in Nature neuroscience (01.02.2004)
Get full text
Journal Article
RGS2 modulates coupling between GABA sub(B) receptors and GIRK channels in dopamine neurons of the ventral tegmental area
Labouebe, Gwenael, Lomazzi, Marta, Cruz, Hans G, Creton, Cyril, Lujan, Rafael, Li, Meng, Yanagawa, Yuchio, Obata, Kunihiko, Watanabe, Masahiko, Wickman, Kevin, Boyer, Stephanie B, Slesinger, Paul A, Luescher, Christian
Published in Nature neuroscience (01.12.2007)
Published in Nature neuroscience (01.12.2007)
Get full text
Journal Article
RGS2 modulates coupling between [GABA.sub.B] receptors and GIRK channels in dopamine neurons of the ventral tegmental area
Labouebe, Gwenael, Lomazzi, Marta, Cruz, Hans G, Creton, Cyril, Lujan, Rafael, Li, Meng, Yanagawa, Yuchio, Obata, Kunihiko, Watanabe, Masahiko, Wickman, Kevin, Boyer, Stephanie B, Slesinger, Paul A, Luscher, Christian
Published in Nature neuroscience (01.12.2007)
Get full text
Published in Nature neuroscience (01.12.2007)
Journal Article
RGS2 modulates coupling between GABA B receptors and GIRK channels in dopamine neurons of the ventral tegmental area
Labouèbe, Gwenaël, Yanagawa, Yuchio, Creton, Cyril, Li, Meng, Obata, Kunihiko, Wickman, Kevin, Cruz, Hans G, Slesinger, Paul A, Luján, Rafael, Lüscher, Christian, Lomazzi, Marta, Watanabe, Masahiko, Boyer, Stephanie B
Published in Nature neuroscience (01.12.2007)
Published in Nature neuroscience (01.12.2007)
Get full text
Journal Article
Bi-directional effects of GABA B receptor agonists on the mesolimbic dopamine system
Slesinger, Paul A, Lüscher, Christian, Cruz, Hans G, Ivanova, Tatiana, Lunn, Marie-Louise, Stoffel, Markus
Published in Nature neuroscience (01.02.2004)
Published in Nature neuroscience (01.02.2004)
Get full text
Journal Article